Year: 2025

DarioHealth Expands GLP-1 Solution with Prescribing Capabilities through Collaboration with MediOrbis, Targeting Employers and Direct-to-Consumer Markets

New collaboration enhances Dario's comprehensive GLP-1 offering with virtual physician management to meet growing demand from employers covering weight-loss medications,...

DarioHealth Expands GLP-1 Solution with Prescribing Capabilities through Collaboration with MediOrbis, Targeting Employers and Direct-to-Consumer Markets

New collaboration enhances Dario's comprehensive GLP-1 offering with virtual physician management to meet growing demand from employers covering weight-loss medications,...

HOPE Therapeutics™, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Alert Investors to Sanjay Gupta/CNN Program on Ketamine, Featuring Kadima Neuropsychiatry Institute Founder Dr. David Feifel

HOPE Therapeutics™, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Alert Investors to Sanjay Gupta/CNN Program on Ketamine, Featuring Kadima Neuropsychiatry Institute Founder Dr. David Feifel

AT J.P. MORGAN HEALTHCARE CONFERENCE, 120/80 GROUP PROJECTS ANOTHER YEAR OF RAPID GROWTH IN HELPING TO ACCELERATE THE CONVERGENCE OF AI AND HEALTH

The Consultancy Announces Executive Hires, New Research and Conference Platforms Focused on Life Sciences and AI NEW YORK and SAN...

Cityblock Health Unveils Third Annual Report Highlighting the Importance of Integrated Care to Address Complexities Faced by Dually Eligible Beneficiaries

BROOKLYN, N.Y., Jan. 14, 2025 /PRNewswire/ -- Cityblock Health, a value-based healthcare provider for Medicaid and dually eligible recipients, today...

error: Content is protected !!